Jaundice for Surgery (MBBS) - Overview

Topic Map

1. Bilirubin physiology & classification of jaundice - pre-hepatic, hepatic, post-hepatic (obstructive); unconjugated vs conjugated hyperbilirubinemia
2. Causes of surgical (obstructive) jaundice - benign (CBD stones, strictures, choledochal cyst, chronic pancreatitis, parasites) vs malignant (cholangiocarcinoma, carcinoma head of pancreas, gallbladder carcinoma, ampullary carcinoma, periampullary tumors)
3. Clinical evaluation - history (painful vs painless jaundice, fever/rigors = Charcot's triad, pruritus, clay-colored stools, dark urine, weight loss), examination (Courvoisier's law, palpable gallbladder, hepatomegaly, signs of chronic liver disease)
4. Investigations - LFTs (bilirubin fractionation, ALP, GGT, transaminases), coagulation profile, USG abdomen, CT/MRCP, ERCP, PTC, tumor markers (CA 19-9, CEA)
5. Pathophysiology of obstructive jaundice and systemic effects - coagulopathy (vitamin K malabsorption), hepatorenal syndrome/risk of acute kidney injury, impaired immune function, wound healing, endotoxemia
6. Preoperative preparation of a jaundiced patient - vitamin K, hydration/mannitol, prophylactic antibiotics, correction of coagulopathy, biliary drainage (PTBD/ERCP stenting) before major surgery
7. Management options - endoscopic (ERCP + sphincterotomy/stenting), percutaneous transhepatic biliary drainage (PTBD), surgical (choledocholithotomy, biliary-enteric bypass, Whipple's procedure for periampullary carcinoma), palliative options
8. Complications of surgical jaundice - cholangitis, hepatorenal syndrome, coagulopathy/bleeding, sepsis, delayed wound healing

Jaundice for Surgery (MBBS) - Overview

Topic Map

1. Bilirubin physiology & classification of jaundice - pre-hepatic, hepatic, post-hepatic (obstructive); unconjugated vs conjugated hyperbilirubinemia
2. Causes of surgical (obstructive) jaundice - benign (CBD stones, strictures, choledochal cyst, chronic pancreatitis, parasites) vs malignant (cholangiocarcinoma, carcinoma head of pancreas, gallbladder carcinoma, ampullary carcinoma, periampullary tumors)
3. Clinical evaluation - history (painful vs painless jaundice, fever/rigors = Charcot's triad, pruritus, clay-colored stools, dark urine, weight loss), examination (Courvoisier's law, palpable gallbladder, hepatomegaly, signs of chronic liver disease)
4. Investigations - LFTs (bilirubin fractionation, ALP, GGT, transaminases), coagulation profile, USG abdomen, CT/MRCP, ERCP, PTC, tumor markers (CA 19-9, CEA)
5. Pathophysiology of obstructive jaundice and systemic effects - coagulopathy (vitamin K malabsorption), hepatorenal syndrome/risk of acute kidney injury, impaired immune function, wound healing, endotoxemia
6. Preoperative preparation of a jaundiced patient - vitamin K, hydration/mannitol, prophylactic antibiotics, correction of coagulopathy, biliary drainage (PTBD/ERCP stenting) before major surgery
7. Management options - endoscopic (ERCP + sphincterotomy/stenting), percutaneous transhepatic biliary drainage (PTBD), surgical (choledocholithotomy, biliary-enteric bypass, Whipple's procedure for periampullary carcinoma), palliative options
8. Complications of surgical jaundice - cholangitis, hepatorenal syndrome, coagulopathy/bleeding, sepsis, delayed wound healing

Jaundice - Complete Surgery MBBS Note

1. Definition and Bilirubin Physiology

• Prehepatic: Senescent RBCs are broken down by the reticuloendothelial system (spleen, liver, bone marrow) into heme, which is converted to unconjugated (indirect) bilirubin. This is insoluble in water and travels bound to albumin to the liver.
• Hepatic: Hepatocytes take up unconjugated bilirubin and conjugate it with glucuronic acid via UDP-glucuronyl transferase, making it water-soluble (conjugated/direct bilirubin), which is then excreted into bile canaliculi.
• Posthepatic: Conjugated bilirubin travels via bile ducts to the duodenum, is converted by gut bacteria to urobilinogen (partly reabsorbed - enterohepatic circulation - and partly excreted as urobilin in urine and stercobilin in stool, giving stool its brown color).

2. Classification of Jaundice

Causes of Obstructive Jaundice (Box format used in Current Surgical Therapy, 14e, p.978)

• Carcinoma of head of pancreas (most common malignant cause)
• Cholangiocarcinoma (Klatskin tumor if at hilum)
• Gallbladder carcinoma
• Ampullary carcinoma
• Periampullary lymph nodes/metastases

• Choledocholithiasis (CBD stone - most common benign/overall cause)
• Benign biliary strictures (post-surgical, e.g., after cholecystectomy)
• Primary/secondary sclerosing cholangitis
• Choledochal cyst
• Chronic pancreatitis (pseudotumoral) causing CBD compression
• Parasites (Ascaris, liver flukes) causing hemobilia
• Mirizzi syndrome (impacted cystic duct stone compressing CBD)

3. Clinical Approach

History - key discriminators

• Pain: Painful jaundice - think stones/cholangitis. Painless progressive jaundice - think malignancy (periampullary/pancreatic head carcinoma). Pye's Surgical Handicraft notes: "a fluctuating jaundice is characteristically that caused by a stone in the bile duct, a progressively deepening jaundice is typical of carcinoma" (Pye's, p. 285).
• Fever with rigors - suggests ascending cholangitis (Charcot's triad: pain + fever + jaundice; Reynolds' pentad adds hypotension + confusion for suppurative cholangitis).
• Pruritus, dark urine (bilirubinuria), pale/clay-colored (acholic) stools - classic of obstructive jaundice due to conjugated bilirubin spilling into urine and absence of bile pigment in gut.
• Weight loss, anorexia - raises suspicion of malignancy.
• Past history: previous biliary surgery, alcohol use, exposure to hepatotoxic drugs, viral hepatitis risk factors, blood transfusions, family history of hemolytic disease.

Examination

• General: pallor (hemolysis), cachexia (malignancy), scratch marks (pruritus), stigmata of chronic liver disease (spider angiomata, palmar erythema, gynecomastia, caput medusae, ascites) suggest hepatocellular cause.
• Abdomen: hepatomegaly, splenomegaly (hemolytic/portal hypertension), and crucially - Courvoisier's Law: "in a jaundiced patient, a palpable, non-tender, enlarged gallbladder is unlikely to be due to gallstones and usually indicates malignant obstruction (commonly periampullary or pancreatic head carcinoma)" - because a gallbladder chronically diseased/scarred by stones cannot distend, whereas malignant obstruction allows gradual painless distension (Bailey & Love's Short Practice of Surgery, 28e; S Das Manual of Clinical Surgery, 13e).

4. Investigations

Laboratory

• Liver function tests with bilirubin fractionation: total, direct (conjugated), indirect (unconjugated) bilirubin. An elevated indirect fraction points to prehepatic/hepatic cause; elevated direct fraction points to obstruction.
• Alkaline phosphatase (ALP) and GGT: markedly raised in cholestasis/obstruction (bile duct epithelium origin); a raised GGT with raised ALP supports a hepatobiliary source rather than bone (Schwartz's, p. 1380).
• Transaminases (AST/ALT): markedly elevated in hepatocellular injury; only mildly elevated in pure obstruction.
• PT/INR: prolonged in obstructive jaundice due to malabsorption of fat-soluble vitamin K (bile needed for its absorption); classically corrects with parenteral vitamin K in obstructive/posthepatic jaundice, but does NOT correct in hepatocellular jaundice because the liver itself cannot synthesize clotting factors - this is a useful bedside differentiating test (Pye's Surgical Handicraft, p. 285).
• CBC: leukocytosis with neutrophilia in cholangitis; reticulocytosis/spherocytosis in hemolysis.
• Viral markers (HBsAg, anti-HCV), tumor markers CA 19-9 (pancreatic/cholangiocarcinoma) and CEA.

Imaging (stepwise approach, Current Surgical Therapy, 14e, p.980-981)

1. Transabdominal ultrasound - first-line; detects biliary dilation and level of obstruction, gallstones, and gallbladder wall changes, though exact cause identified in only about two-thirds of cases and sensitivity for CBD stones is only 21-63%.
2. CT abdomen - highly sensitive for pancreatic head masses (especially >2 cm) and staging.
3. MRCP - excellent noninvasive test for biliary tree evaluation; ~95% sensitivity for detecting the level/cause of obstruction and the best noninvasive test for choledocholithiasis, but purely diagnostic (no therapeutic capability).
4. Endoscopic ultrasound (EUS) - superior for ampullary/pancreatic head lesions, vascular invasion, and can obtain FNA cytology (sensitivity 84-91% with FNA).
5. ERCP - combines diagnosis (cholangiogram) with therapy (sphincterotomy, stone extraction, stenting) in the same session; cannulation success >90%.
6. PTC (percutaneous transhepatic cholangiography) - used when ERCP fails or is not feasible (e.g., altered anatomy, hilar strictures), can be combined with percutaneous biliary drainage (PTBD).

5. Pathophysiology and Systemic Effects of Obstructive Jaundice (why surgeons worry)

• Coagulopathy: Absence of bile in the gut impairs absorption of fat-soluble vitamins (A, D, E, K). Vitamin K deficiency reduces synthesis of factors II, VII, IX, X, prolonging PT/INR and increasing bleeding risk at surgery.
• Renal impairment ("hepatorenal syndrome of obstructive jaundice" / cholemic nephrosis): endotoxemia, altered renal hemodynamics, and direct toxic effects of bile salts predispose to acute kidney injury, especially after operative stress, hypotension, or contrast administration. This is why perioperative hydration is emphasized.
• Impaired immune function and endotoxemia: absence of bile salts in the gut lumen allows increased bacterial translocation and endotoxin absorption via the portal circulation, since Kupffer cell clearance is also impaired - predisposing to sepsis and poor wound healing.
• Risk of cholangitis: stagnant, obstructed bile is prone to bacterial infection, producing Charcot's triad or, if septic and hypotensive/confused, Reynolds' pentad - a surgical emergency requiring urgent decompression.
• Malnutrition: fat malabsorption (steatorrhea) from lack of bile salts in the gut.

6. Preoperative Preparation of the Jaundiced Patient

1. Correct coagulopathy: Parenteral vitamin K (responds well in obstructive jaundice); fresh frozen plasma if actively bleeding or urgent surgery needed and INR remains high.
2. Hydration and renal protection: IV fluids to maintain good urine output before and during any procedure/surgery/contrast studies; some units use mannitol as an osmotic diuretic to reduce risk of hepatorenal injury.
3. Antibiotic prophylaxis: broad-spectrum antibiotics covering gram-negative enteric organisms, since bile is often colonized in obstruction and instrumentation (ERCP/surgery) can precipitate cholangitis/sepsis.
4. Nutritional optimization: correct hypoproteinemia; consider preoperative biliary drainage in deeply jaundiced patients undergoing major resection (e.g., pancreaticoduodenectomy/Whipple's), particularly with prolonged or severe jaundice or if surgery will be delayed - though this remains debated, as routine preoperative biliary drainage has NOT been shown to consistently reduce postoperative morbidity in Whipple candidates and can add its own complications (stent-related cholangitis) - individualize based on severity and duration of jaundice, degree of malnutrition, and anticipated delay to surgery.
5. Treat cholangitis first if present: broad-spectrum antibiotics plus urgent biliary decompression (ERCP preferred) take priority over elective workup.

7. Management (Definitive Treatment)

• Endoscopic (ERCP): first-line for distal CBD obstruction - sphincterotomy with stone extraction (basket/balloon) for choledocholithiasis; plastic or metal stent placement for strictures/malignant obstruction (often as a bridge to surgery or for palliation in unresectable cancer).
• Percutaneous transhepatic biliary drainage (PTBD): used when ERCP fails or anatomy precludes endoscopic access (e.g., hilar/Klatskin tumors, altered surgical anatomy, duodenal obstruction).
• Surgical options:
  • Choledocholithotomy/CBD exploration for stones not amenable to endoscopic clearance
  • Biliary-enteric bypass (choledochojejunostomy, hepaticojejunostomy) for benign strictures or palliation of unresectable malignancy
  • Pancreaticoduodenectomy (Whipple's procedure) for resectable periampullary/pancreatic head carcinoma - the definitive curative option
  • Cholecystojejunostomy or biliary bypass for palliation when resection is not feasible
• Management of cholangitis takes priority when coexisting - urgent decompression (ERCP usually) plus IV antibiotics, following the principle that "the management of patients with obstructive jaundice depends on whether there is coexisting cholangitis" (Pye's Surgical Handicraft, p. 285).

8. Complications to Remember for Exams

• Ascending cholangitis / sepsis
• Hepatorenal syndrome / acute kidney injury
• Coagulopathy and perioperative hemorrhage
• Delayed wound healing, wound dehiscence
• Malnutrition, fat-soluble vitamin deficiency
• Post-ERCP complications: pancreatitis, perforation, bleeding, cholangitis